INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

49 hedge funds and large institutions have $183M invested in Inozyme Pharma in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 5 closing their positions.

Holders
49
Holders Change
+12
Holders Change %
+32.43%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
17
Increased
18
Reduced
5
Closed
5
Calls
$166K
Puts
$378K
Net Calls
-$212K
Net Calls Change
-$212K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$9.69M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$24.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$4.55M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$4.03M
5
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$18.4M

Top Sellers

1
CA
1
CHI Advisors
New York
$7.69M
2
VA
2
VR Adviser
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.07M
4
BCM
4
Bridgeway Capital Management
Texas
$673K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.61M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$24.4M 4,265,138 +1,165,000 +38%
SI
2
Sofinnova Investments
California
$20.9M 3,655,308 – –
DTC
3
Deep Track Capital
Connecticut
$18.6M 3,250,000 – –
RSCM
4
Rock Springs Capital Management
Maryland
$18.4M 3,214,900 +128,873 +4%
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$18.4M 3,213,586 +552,432 +21%
NMC
6
NEA Management Company
Maryland
$14M 2,437,689 – –
SFM
7
Sphera Funds Management
Israel
$10.2M 1,781,858 +156,800 +10%
Millennium Management
8
Millennium Management
New York
$9.69M 1,691,075 +1,393,139 +468%
CA
9
CHI Advisors
New York
$7.69M 1,342,191 -862,685 -39%
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.61M 1,328,290 -15,332 -1%
Citadel Advisors
11
Citadel Advisors
Florida
$4.55M 793,823 +793,823 New
AAA
12
Affinity Asset Advisors
New York
$4.31M 751,796 +251,796 +50%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$4.03M 702,996 +702,996 New
SB
14
Samsara BioCapital
California
$2.89M 504,407 +504,407 New
BlackRock
15
BlackRock
New York
$2.59M 451,193 +24,969 +6%
LCM
16
Laurion Capital Management
New York
$1.56M 271,800 – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.38M 241,208 +8,082 +3%
MB
18
MPM BioImpact
Massachusetts
$1.34M 233,728 +3,228 +1%
OMC
19
Overbrook Management Corp
New York
$1.26M 219,326 – –
Marshall Wace
20
Marshall Wace
United Kingdom
$1.12M 195,097 +195,097 New
Renaissance Technologies
21
Renaissance Technologies
New York
$1.07M 186,100 -72,800 -28%
DMKJ
22
David M. Knott Jr
$917K 160,000 +160,000 New
UOC
23
UBS O'Connor
Illinois
$846K 147,654 +147,654 New
PHP
24
Parkman Healthcare Partners
Connecticut
$716K 125,000 +125,000 New
BCM
25
Bridgeway Capital Management
Texas
$673K 117,400 -16,000 -12%
1
2 3